Choreo LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
49,774
+1,855
| +4% | +$72K | 0.03% | 375 |
|
|
2025
Q1 | $1.88M | Sell |
47,919
-4,832
| -9% | -$190K | 0.03% | 349 |
|
|
2024
Q4 | $1.78M | Sell |
52,751
-1,929
| -4% | -$64.9K | 0.03% | 389 |
|
|
2024
Q3 | $2.22M | Buy |
54,680
+2,523
| +5% | +$103K | 0.03% | 329 |
|
|
2024
Q2 | $2M | Buy |
52,157
+46,088
| +759% | +$1.77M | 0.03% | 319 |
|
|
2024
Q1 | $260K | Sell |
6,069
-1,380
| -19% | -$59.2K | 0.01% | 568 |
|
|
2023
Q4 | $279K | Buy |
7,449
+1,570
| +27% | +$58.8K | 0.01% | 512 |
|
|
2023
Q3 | $215K | Sell |
5,879
-575
| -9% | -$21K | 0.01% | 434 |
|
|
2023
Q2 | $232K | Buy |
6,454
+109
| +2% | +$3.92K | 0.01% | 420 |
|
|
2023
Q1 | $226K | Buy |
+6,345
| New | +$226K | 0.01% | 442 |
|
|
2018
Q4 | – | Sell |
-4,618
| Closed | -$235K | – | 198 |
|
|
2018
Q3 | $235K | Buy |
4,618
+414
| +10% | +$21.1K | 0.03% | 193 |
|
|
2018
Q2 | $214K | Buy |
+4,204
| New | +$214K | 0.03% | 221 |
|
|
2017
Q4 | – | Sell |
-5,154
| Closed | -$265K | – | 291 |
|
|
2017
Q3 | $265K | Buy |
5,154
+948
| +23% | +$48.7K | 0.03% | 230 |
|
|
2017
Q2 | $229K | Sell |
4,206
-17
| -0.4% | -$926 | 0.03% | 239 |
|
|
2017
Q1 | $226K | Sell |
4,223
-139
| -3% | -$7.44K | 0.03% | 238 |
|
|
2016
Q4 | $212K | Buy |
4,362
+169
| +4% | +$8.21K | 0.03% | 234 |
|
|
2016
Q3 | $228K | Buy |
+4,193
| New | +$228K | 0.04% | 208 |
|